These results suggest that ADAM17 downregulation may play a role in preserving normal organization of the actin cytoskeleton in podocytes under hyperglycemic conditions, which could be relevant in the context of diabetes where hyperglycemia can impact kidney function. Here, ADAM17 is linked to diabetes mellitus.